MYRIAD GENETICS, INC. Costs and Expenses
MYRIAD GENETICS, INC. (MYGN) reported Costs and Expenses of $233.30 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2024-11-08
- MYRIAD GENETICS, INC. costs and expenses for the quarter ending 2024-09-30 was $233.30M, a 7.42% decline year-over-year.
- MYRIAD GENETICS, INC. costs and expenses for the quarter ending 2024-06-30 was $248.00M, a 16.55% decline year-over-year.
- MYRIAD GENETICS, INC. costs and expenses for the quarter ending 2024-03-31 was $230.10M, a 1.41% decline year-over-year.
- MYRIAD GENETICS, INC. costs and expenses for the quarter ending 2023-12-31 was $228.00M, a 0.87% decline year-over-year.
- MYRIAD GENETICS, INC. costs and expenses for fiscal 2023 was $1.01B, a 23.39% increase from fiscal 2022.
- MYRIAD GENETICS, INC. costs and expenses for fiscal 2022 was $819.00M, a 7.05% decline from fiscal 2021.
- MYRIAD GENETICS, INC. costs and expenses for fiscal 2021 was $881.10M, a 4.05% increase from fiscal 2020.
- MYRIAD GENETICS, INC. costs and expenses for fiscal 2020 was $846.80M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $233.30M 10-Q · filed 2024-11-08 | $481.30M derived: sum of 2 quarters · filed 2024-11-08 | $711.50M 10-Q · filed 2024-11-08 | $939.40M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2024-06-30 | $248.00M 10-Q · filed 2024-08-07 | $478.10M 10-Q · filed 2024-08-07 | $706.10M derived: sum of 3 quarters · filed 2024-08-07 | $958.10M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2024-03-31 | $230.10M 10-Q · filed 2024-05-08 | $458.10M derived: sum of 2 quarters · filed 2024-05-08 | $710.10M derived: sum of 3 quarters · filed 2024-11-08 | $1.01B derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-12-31 | $228.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $480.00M derived: sum of 2 quarters · filed 2024-11-08 | $777.20M derived: sum of 3 quarters · filed 2024-11-08 | $1.01B 10-K · filed 2024-02-28 | ||||
| 2023-09-30 | $252.00M 10-Q · filed 2024-11-08 | $549.20M derived: sum of 2 quarters · filed 2024-11-08 | $782.60M 10-Q · filed 2024-11-08 | $1.01B derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $297.20M 10-Q · filed 2024-08-07 | $530.60M 10-Q · filed 2024-08-07 | $760.60M derived: sum of 3 quarters · filed 2024-08-07 | $962.00M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $233.40M 10-Q · filed 2024-05-08 | $463.40M derived: sum of 2 quarters · filed 2024-05-08 | $664.80M derived: sum of 3 quarters · filed 2024-05-08 | $861.90M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $230.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $431.40M derived: sum of 2 quarters · filed 2024-02-28 | $628.50M derived: sum of 3 quarters · filed 2024-02-28 | $819.00M 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | $201.40M 10-Q · filed 2023-11-07 | $398.50M derived: sum of 2 quarters · filed 2023-11-07 | $589.00M 10-Q · filed 2023-11-07 | $792.90M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $197.10M 10-Q · filed 2023-08-04 | $387.60M 10-Q · filed 2023-08-04 | $591.50M derived: sum of 3 quarters · filed 2024-02-28 | $838.70M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $190.50M 10-Q · filed 2023-05-04 | $394.40M derived: sum of 2 quarters · filed 2024-02-28 | $641.60M derived: sum of 3 quarters · filed 2024-02-28 | $851.80M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $203.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $451.10M derived: sum of 2 quarters · filed 2024-02-28 | $661.30M derived: sum of 3 quarters · filed 2024-02-28 | $881.10M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $247.20M 10-Q · filed 2022-11-02 | $457.40M derived: sum of 2 quarters · filed 2022-11-02 | $677.20M 10-Q · filed 2022-11-02 | $880.00M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $210.20M 10-Q · filed 2022-08-05 | $430.00M 10-Q · filed 2022-08-05 | $632.80M derived: sum of 3 quarters · filed 2022-08-05 | $817.60M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $219.80M 10-Q · filed 2022-05-06 | $422.60M derived: sum of 2 quarters · filed 2022-05-06 | $607.40M derived: sum of 3 quarters · filed 2022-05-06 | $768.90M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $202.80M 10-KT · filed 2021-03-16 | $387.60M 10-K · filed 2023-03-01 | $549.10M derived: sum of 3 quarters · filed 2021-11-04 | $846.80M 10-K · filed 2022-02-25 | ||||
| 2020-09-30 | $184.80M 10-Q · filed 2021-11-04 | $346.30M derived: sum of 2 quarters · filed 2021-11-04 | $644.00M 10-Q · filed 2021-11-04 | $847.90M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $161.50M 10-Q · filed 2021-08-04 | $459.20M 10-Q · filed 2021-08-04 | $663.10M derived: sum of 3 quarters · filed 2021-08-04 | $870.30M 10-K · filed 2023-03-01 | ||||
| 2020-03-31 | $297.70M 10-Q · filed 2021-05-05 | $501.60M derived: sum of 2 quarters · filed 2021-05-05 | $708.80M 10-Q · filed 2020-05-06 | $929.80M derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2019-12-31 | $203.90M 10-KT · filed 2021-03-16 | $411.10M 10-K · filed 2022-02-25 | $632.10M derived: sum of 3 quarters · filed 2021-03-16 | $842.80M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-09-30 | $207.20M 10-KT · filed 2021-03-16 | $428.20M derived: sum of 2 quarters · filed 2021-03-16 | $638.90M derived: sum of 3 quarters · filed 2021-03-16 | $849.60M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-06-30 | $221.00M 10-KT · filed 2021-03-16 | $431.70M derived: sum of 2 quarters · filed 2021-03-16 | $642.40M derived: sum of 3 quarters · filed 2021-03-16 | $843.50M 10-K · filed 2022-02-25 | ||||
| 2019-03-31 | $210.70M 10-KT · filed 2021-03-16 | $421.40M derived: sum of 2 quarters · filed 2021-03-16 | $622.50M 10-Q · filed 2020-05-06 | $798.60M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-12-31 | $210.70M 10-KT · filed 2021-03-16 | $411.80M 10-Q · filed 2020-02-07 | $587.90M derived: sum of 3 quarters · filed 2021-03-16 | $757.20M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-09-30 | $201.10M 10-KT · filed 2021-03-16 | $377.20M derived: sum of 2 quarters · filed 2021-03-16 | $546.50M derived: sum of 3 quarters · filed 2021-03-16 | $728.10M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-06-30 | $176.10M 10-K · filed 2019-08-13 | $185.00M 10-K · filed 2018-08-24 | $345.40M derived: sum of 2 quarters · filed 2019-08-13 | $527.00M derived: sum of 3 quarters · filed 2019-08-13 | $621.80M 10-KT · filed 2021-03-16 | $653.90M 10-K · filed 2018-08-24 | ||
| 2018-03-31 | $169.30M 10-K · filed 2019-08-13 | $176.50M 10-Q · filed 2018-05-09 | $350.90M derived: sum of 2 quarters · filed 2019-08-13 | $445.50M 10-Q · filed 2019-05-08 | $468.70M 10-Q · filed 2018-05-09 | $626.40M derived: sum of 4 quarters · filed 2019-08-13 | ||
| 2017-12-31 | $181.60M 10-K · filed 2019-08-13 | $189.60M 10-Q · filed 2018-02-07 | $276.40M 10-Q · filed 2019-02-06 | $292.30M 10-Q · filed 2018-02-07 | $457.10M derived: sum of 3 quarters · filed 2019-08-13 | $646.30M derived: sum of 4 quarters · filed 2019-08-13 | ||
| 2017-09-30 | $94.80M 10-K · filed 2019-08-13 | $102.80M 10-Q · filed 2017-11-08 | $275.50M derived: sum of 2 quarters · filed 2019-08-13 | $464.70M derived: sum of 3 quarters · filed 2019-08-13 | $644.20M derived: sum of 4 quarters · filed 2019-08-13 | |||
| 2017-06-30 | $180.70M 10-K · filed 2018-08-24 | $369.90M derived: sum of 2 quarters · filed 2018-08-24 | $549.40M derived: sum of 3 quarters · filed 2018-08-24 | $684.70M 10-K · filed 2019-08-13 | $722.00M 10-K · filed 2017-08-09 | |||
| 2017-03-31 | $189.20M 10-K · filed 2018-08-24 | $184.00M 10-Q · filed 2017-05-03 | $368.70M derived: sum of 2 quarters · filed 2018-08-24 | $540.50M 10-Q · filed 2018-05-09 | $538.50M 10-Q · filed 2017-05-03 | $691.40M derived: sum of 4 quarters · filed 2018-08-24 | ||
| 2016-12-31 | $179.50M 10-K · filed 2018-08-24 | $183.30M 10-Q · filed 2017-02-08 | $351.30M 10-Q · filed 2018-02-07 | $354.50M 10-Q · filed 2017-02-08 | $502.20M derived: sum of 3 quarters · filed 2018-08-24 | $650.10M derived: sum of 4 quarters · filed 2018-08-24 | ||
| 2016-09-30 | $171.80M 10-K · filed 2018-08-24 | $171.30M 10-Q · filed 2016-11-02 | $322.70M derived: sum of 2 quarters · filed 2018-08-24 | $470.60M derived: sum of 3 quarters · filed 2018-08-24 | $618.70M derived: sum of 4 quarters · filed 2018-08-24 | |||
| 2016-06-30 | $150.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $298.80M derived: sum of 2 quarters · filed 2018-08-24 | $446.90M derived: sum of 3 quarters · filed 2018-08-24 | $587.10M 10-K · filed 2018-08-24 | $587.00M 10-K · filed 2016-08-10 | |||
| 2016-03-31 | $147.90M 10-Q · filed 2017-05-03 | $296.00M derived: sum of 2 quarters · filed 2017-05-03 | $436.20M 10-Q · filed 2017-05-03 | $589.90M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2015-12-31 | $148.10M 10-Q · filed 2017-02-08 | $288.30M 10-Q · filed 2017-02-08 | $442.00M derived: sum of 3 quarters · filed 2018-08-24 | $586.30M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2015-09-30 | $140.20M 10-Q · filed 2016-11-02 | $293.90M derived: sum of 2 quarters · filed 2018-08-24 | $438.20M derived: sum of 3 quarters · filed 2018-08-24 | $586.30M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2015-06-30 | $153.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $298.00M derived: sum of 2 quarters · filed 2018-08-24 | $446.10M derived: sum of 3 quarters · filed 2018-08-24 | $588.90M 10-K · filed 2018-08-24 | ||||
| 2015-03-31 | $144.30M 10-Q · filed 2016-05-04 | $144.25M 10-Q · filed 2015-05-06 | $292.40M derived: sum of 2 quarters · filed 2016-05-04 | $435.20M 10-Q · filed 2016-05-04 | $435.21M 10-Q · filed 2015-05-06 | $570.84M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-12-31 | $148.10M 10-Q · filed 2016-02-03 | $148.05M 10-Q · filed 2015-02-04 | $290.90M 10-Q · filed 2016-02-03 | $290.97M 10-Q · filed 2015-02-04 | $426.54M derived: sum of 3 quarters · filed 2016-08-10 | $554.17M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-09-30 | $142.90M 10-Q · filed 2015-11-04 | $142.92M 10-Q · filed 2014-11-05 | $278.44M derived: sum of 2 quarters · filed 2016-08-10 | $406.07M derived: sum of 3 quarters · filed 2016-08-10 | $527.14M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-06-30 | $135.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | $263.18M derived: sum of 2 quarters · filed 2016-08-10 | $384.24M derived: sum of 3 quarters · filed 2016-08-10 | $503.80M 10-K · filed 2016-08-10 | $503.77M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | $127.64M 10-Q · filed 2015-05-06 | $248.70M derived: sum of 2 quarters · filed 2015-05-06 | $368.26M 10-Q · filed 2015-05-06 | $476.50M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-12-31 | $121.06M 10-Q · filed 2015-02-04 | $240.62M 10-Q · filed 2015-02-04 | $348.86M derived: sum of 3 quarters · filed 2015-08-12 | $447.41M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-09-30 | $119.56M 10-Q · filed 2014-11-05 | $227.80M derived: sum of 2 quarters · filed 2015-08-12 | $326.35M derived: sum of 3 quarters · filed 2015-08-12 | $419.91M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-06-30 | $108.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $206.79M derived: sum of 2 quarters · filed 2015-08-12 | $300.34M derived: sum of 3 quarters · filed 2015-08-12 | $385.20M 10-K · filed 2015-08-12 | $385.16M 10-K · filed 2013-08-14 | |||
| 2013-03-31 | $98.55M 10-Q · filed 2014-05-07 | $192.11M derived: sum of 2 quarters · filed 2014-05-07 | $276.96M 10-Q · filed 2014-05-07 | $362.64M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-12-31 | $93.55M 10-Q · filed 2014-02-05 | $178.41M 10-Q · filed 2014-02-05 | $264.09M derived: sum of 3 quarters · filed 2014-08-13 | $347.77M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-09-30 | $84.86M 10-Q · filed 2013-11-12 | $170.53M derived: sum of 2 quarters · filed 2014-08-13 | $254.22M derived: sum of 3 quarters · filed 2014-08-13 | $331.56M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-06-30 | $85.68M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $169.36M derived: sum of 2 quarters · filed 2014-08-13 | $246.71M derived: sum of 3 quarters · filed 2014-08-13 | $315.69M 10-K · filed 2014-08-13 | ||||
| 2012-03-31 | $83.68M 10-Q · filed 2013-05-08 | $161.03M derived: sum of 2 quarters · filed 2013-05-08 | $230.01M 10-Q · filed 2013-05-08 | $295.64M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-12-31 | $77.35M 10-Q · filed 2013-02-06 | $146.33M 10-Q · filed 2013-02-06 | $211.96M derived: sum of 3 quarters · filed 2013-08-14 | $272.51M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-09-30 | $68.98M 10-Q · filed 2012-11-09 | $134.62M derived: sum of 2 quarters · filed 2013-08-14 | $195.16M derived: sum of 3 quarters · filed 2013-08-14 | $257.02M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-06-30 | $65.64M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $126.19M derived: sum of 2 quarters · filed 2013-08-14 | $188.04M derived: sum of 3 quarters · filed 2013-08-14 | $244.31M 10-K · filed 2013-08-14 | ||||
| 2011-03-31 | $60.55M 10-Q · filed 2012-05-02 | $122.40M derived: sum of 2 quarters · filed 2012-05-02 | $178.67M 10-Q · filed 2012-05-02 | $234.98M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-12-31 | $61.85M 10-Q · filed 2012-02-01 | $118.12M 10-Q · filed 2012-02-01 | $174.43M derived: sum of 3 quarters · filed 2012-08-15 | $232.04M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-09-30 | $56.27M 10-Q · filed 2011-11-02 | $112.58M derived: sum of 2 quarters · filed 2012-08-15 | $170.19M derived: sum of 3 quarters · filed 2012-08-15 | $228.43M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-06-30 | $56.31M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-15 | $113.92M derived: sum of 2 quarters · filed 2012-08-15 | $172.16M derived: sum of 3 quarters · filed 2012-08-15 | $227.57M 10-K · filed 2012-08-15 | ||||
| 2010-03-31 | $57.60M 10-Q · filed 2011-05-04 | $115.85M derived: sum of 2 quarters · filed 2011-05-04 | $171.26M 10-Q · filed 2011-05-04 | |||||
| 2009-12-31 | $58.25M 10-Q · filed 2011-02-01 | $113.66M 10-Q · filed 2011-02-01 | ||||||
| 2009-09-30 | $55.41M 10-Q · filed 2010-11-03 | |||||||
| 2009-06-30 | $200.06M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |